Related Experiment Video
Updated: Jul 12, 2025

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
Published on: August 20, 2019
[Research progress on the role and mechanism of endothelial dysfunction in hyperhomocysteine-induced atherosclerosis]
Cheng-Yan Wu1, Xu-Lei Duan1, Li-Bo Wang1
1Department of Cardiology, The First Affiliated Hospital of Xinxiang Medical University; Heart Center of Xinxiang Medical University, Xinxiang 453100, China.
Insights
High homocysteine levels (HHcy) are linked to cardiovascular disease risk. HHcy causes endothelial dysfunction through various molecular pathways, including endothelial mesenchymal transition, contributing to vascular damage.
Area of Science:
- Cardiovascular Science
- Molecular Biology
- Pathophysiology
Background:
- Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular diseases.
- The precise molecular mechanisms linking HHcy to vascular pathogenesis remain unclear.
- Endothelial dysfunction is a critical early event in atherosclerosis and HHcy-related vascular diseases.
Approach:
- This review synthesizes current research on the molecular links between HHcy and endothelial dysfunction.
- It specifically examines how HHcy impacts endothelial cells.
- The review highlights the role of endothelial mesenchymal transition in HHcy-induced vascular damage.
Key Points:
- HHcy induces endothelial dysfunction by promoting oxidative stress, inhibiting nitric oxide and hydrogen sulfide pathways.
- HHcy also triggers endothelial mesenchymal transition, activates coagulation, and causes protein N-homocysteination and cellular hypomethylation.
- Endothelial mesenchymal transition is identified as a significant contributor to HHcy-mediated vascular injury.
Conclusions:
- HHcy contributes to vascular disease through multiple detrimental effects on endothelial cells.
- Endothelial mesenchymal transition represents a key mechanism in HHcy-induced vascular damage.
- Understanding these pathways may offer novel therapeutic strategies for HHcy-related vascular conditions.
Abstract:
Hyperhomocysteinemia (HHcy) is considered to be an independent risk factor for cardiovascular diseases, but the molecular mechanisms underlying its pathogenesis are not fully understood. Endothelial dysfunction is a key initiating factor in the pathogenesis of atherosclerosis, which is commonly observed in almost all HHcy-induced vascular diseases. HHcy promotes oxidative stress, inhibits nitric oxide production, suppresses hydrogen sulfide signaling pathway, promotes endothelial mesenchymal transition, activates coagulation pathways, and promotes protein N-homocysteination and cellular hypomethylation, all of which can cause endothelial dysfunction. This article reviews the specific links between HHcy and endothelial dysfunction, and highlights recent evidence that endothelial mesenchymal transition contributes to HHcy-induced vascular damage, with a hope to provide new ideas for the clinical treatment of HHcy-related vascular diseases.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hypertension II: Pathophysiology

